NYKODE THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.67 NOK | -0.41% |
|
+7.79% | -31.45% |
| May. 14 | Transcript : Nykode Therapeutics AS, Q1 2024 Earnings Call, May 14, 2024 | |
| May. 14 | Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 449M | - | |||||
| 113B | ||||||
| 106B | ||||||
| 22.27B | - | |||||
| 22.22B | - | |||||
| 19.43B |
- Stock Market
- Equities
- NYKD Stock
- Charts Nykode Therapeutics
- Sector Chart